Please complete the CAPTCHA to continue
@excite.com
✓
3 phones found area 973 and 650
✓
LinkedIn matched
A concise factual answer block for searchers comparing this professional profile.
Mark Foreman is listed as Consultant at Mark Foreman and Associates, based in San Mateo, California, United States. AeroLeads shows a work email signal at excite.com, phone signal with area code 973, 650, and a matched LinkedIn profile for Mark Foreman.
Mark Foreman previously worked as Senior Director Preclinical Research and Development at Jazz Pharmaceuticals and Senior Director of Research and Development at Neotherapeutics. Mark Foreman holds Postdoctoral Fellow, Neuroendocrinology And Neurochemistry from The University Of Texas Southwestern Medical School.
This section adds company-level context without repeating Mark Foreman's masked contact details.
AeroLeads found 1 current-domain work email signal for Mark Foreman. Compare company email patterns before reaching out.
Mark Foreman is a Consultant at Mark Foreman and Associates. He possess expertise in biotechnology, clinical trials, cro, neuroscience, biochemistry and 14 more skills.
Listed skills include Biotechnology, Clinical Trials, Cro, Neuroscience, and 15 others.
Company context helps verify the profile and gives searchers a useful next step.
A career timeline built from the work history available for this profile.
Provided guidance for discovery and nonclinical development research to biotech and pharmaceutical companies. Identified CROs and academic research centers for targeted research and managing research efforts.
Developed strategic preclinical discovery, nonclinical development and clinical research plans. Provided scientific evaluation of potential licensing candidates and new development candidates. Provided connections for licensing opportunities. Wrote nonclinical research reports, manuscripts and patents.
Managed preclinical research strategy and extramural research.Initiated and completed patent protection research that broadened the coverage to include novel platforms and wrote 8 patents to cover these discoveries.Created 6 novel chemical platforms resulting in 3 clinical trial candidates for severe dementia, Alzheimer's disease, attention deficit disorder and schizophrenia. Developed contract research to study bioavailability, memory retention in aged animals, and efficacy in Parkinson's disease, Huntington's disease and drug-induced neuropathies.Wrote and submitted IND documentation for NEO-082, NEO-339, NEO-376 and NEO-392.Wrote 6 abstracts and 2 manuscripts to enhance corporate scientific credibility.
Designed and implemented of pharmacological research programs in Korea and New Jersey research centers for neuropharmacology, neurochemistry, psychopharmacology and medicinal chemistry. Created new research programs for anxiety, bipolar disorder and neuropathic pain. Coordinated pharmacology and toxicology efforts with preclinical CROs and prepared reports and reviews for IND preparation. Developed and managed Phase I and II research programs in conjunction with CROs. Completed Phase I/II clinical development programs for licensing of an anticonvulsant with analgesic and mood stabilizing activity (YKP509) and antidepressants (YKP10A and YKP581).Presented scientific summaries to potential licensing partners resulting in three compounds licensed to Johnson and Johnson.
Divisions of Central Nervous System and Endocrine Research Program Chairman/Group Leader - Research Strategy Group Member Developed, implemented and evaluated research strategies and designed preclinical studies to define mechanisms of action and therapeutic application for new drug candidates.Chaired 7 R & D programs which advanced 13 compounds to clinical trials. Scientific contributions included behavioral characterization of agonists and antagonists for the 5-HT1A, 5-HT2, 5-HT1D, and D1 and D3 dopaminergic receptors, and biochemical characterization of NK1/NK2 antagonists and ion channel associated excitatory amino acid receptor antagonists.
Departments of Physiology and Obstetrics/Gynecology NIH Postdoctoral Fellow in Neuroendocrinology; Green Foundation Research Fellow
NIH Predoctoral Fellow in Psychoneuroendocrinology Research Focus: Endocrinology, Neurochemistry and Psychoneuroendocrinology
Quick answers generated from the profile data available on this page.
Mark Foreman works for Mark Foreman and Associates.
Mark Foreman is listed as Consultant at Mark Foreman and Associates.
AeroLeads has found 1 work email signal at @excite.com for Mark Foreman at Mark Foreman and Associates.
AeroLeads has found 3 phone signal(s) with area code 973, 650 for Mark Foreman at Mark Foreman and Associates.
Mark Foreman is based in San Mateo, California, United States while working with Mark Foreman and Associates.
Mark Foreman has worked for Mark Foreman And Associates, Jazz Pharmaceuticals, Neotherapeutics, Sk Corporation, and Eli Lilly And Co.
You can use AeroLeads to view verified contact signals for Mark Foreman at Mark Foreman and Associates, including work email, phone, and LinkedIn data when available.
Mark Foreman holds Postdoctoral Fellow, Neuroendocrinology And Neurochemistry from The University Of Texas Southwestern Medical School.
Mark Foreman is listed with skills including Biotechnology, Clinical Trials, Cro, Neuroscience, Biochemistry, Biopharmaceuticals, Clinical Research, and Pharmaceutics.
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial Search contactsCheck these profiles if this is not the Mark Foreman you were looking for.
View similar profiles
